Loading...

argenx SE

ARGX•NASDAQ
Healthcare
Biotechnology
$780.25
$-7.70(-0.98%)
U.S. Market opens in 49h 13m

argenx SE (ARGX) Stock Overview

Explore argenx SE’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap48.3B
P/E Ratio22.26
EPS (TTM)$19.61
ROE0.34%
Fundamental Analysis

AI Price Forecasts

1 Month$695.48
3 Months$774.20
1 Year Target$821.95

ARGX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of argenx SE (ARGX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 50.14, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $821.95.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 22.26 and a market capitalization of 48.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.98%
5-Day Change
-8.10%
1-Month Change
15.17%
3-Month Change
-4.23%
6-Month Change
-4.54%
Year-to-Date (YTD) Change
-7.22%
1-Year Change
29.93%
3-Year Change
99.49%
5-Year Change
166.27%
All-Time (Max) Change
3292.39%

Contact Information

https://www.argenx.com
31 10 703 8441
Laarderhoogtweg 25, Amsterdam, NaN, 1101EB

Company Facts

1,599 Employees
IPO DateMay 18, 2017
CountryNL
Actively Trading

Frequently Asked Questions